More Stories

cure trpx

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids

OXNARD, California and TEL AVIV, Israel, July 11, 2017 /PRNewswire/ — CURE Pharmaceutical (OTCQB: CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule d…